Lantheus Holdings, Inc. Cost of Revenue
Lantheus Holdings, Inc. (LNTH) reported Cost of Revenue of $146.32 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- Lantheus Holdings, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $146.32M, a 6.78% increase year-over-year.
- Lantheus Holdings, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $146.41M, a 8.40% increase year-over-year.
- Lantheus Holdings, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $165.91M, a 16.38% increase year-over-year.
- Lantheus Holdings, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $161.65M, a 18.33% increase year-over-year.
- Lantheus Holdings, Inc. cost of goods and services sold for fiscal 2025 was $599.66M, a 9.90% increase from fiscal 2024.
- Lantheus Holdings, Inc. cost of goods and services sold for fiscal 2024 was $545.62M, a 7.03% decline from fiscal 2023.
- Lantheus Holdings, Inc. cost of goods and services sold for fiscal 2023 was $586.89M, a 66.09% increase from fiscal 2022.
- Lantheus Holdings, Inc. cost of goods and services sold for fiscal 2022 was $353.36M, a 48.77% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $146.32M 10-Q · filed 2026-08-06 | $292.74M 10-Q · filed 2026-08-06 | $458.65M derived: sum of 3 quarters · filed 2026-08-06 | $620.29M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $146.41M 10-Q · filed 2026-05-07 | $312.32M derived: sum of 2 quarters · filed 2026-05-07 | $473.97M derived: sum of 3 quarters · filed 2026-05-07 | $611.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $165.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $327.56M derived: sum of 2 quarters · filed 2026-02-26 | $464.59M derived: sum of 3 quarters · filed 2026-08-06 | $599.66M 10-K · filed 2026-02-26 |
| 2025-09-30 | $161.65M 10-Q · filed 2025-11-06 | $298.68M derived: sum of 2 quarters · filed 2026-08-06 | $433.75M 10-Q · filed 2025-11-06 | $576.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $137.03M 10-Q · filed 2026-08-06 | $272.10M 10-Q · filed 2026-08-06 | $414.66M derived: sum of 3 quarters · filed 2026-08-06 | $551.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $135.06M 10-Q · filed 2026-05-07 | $277.63M derived: sum of 2 quarters · filed 2026-05-07 | $414.24M derived: sum of 3 quarters · filed 2026-05-07 | $552.55M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $142.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $279.17M derived: sum of 2 quarters · filed 2026-02-26 | $417.49M derived: sum of 3 quarters · filed 2026-02-26 | $545.62M 10-K · filed 2026-02-26 |
| 2024-09-30 | $136.61M 10-Q · filed 2025-11-06 | $274.93M derived: sum of 2 quarters · filed 2025-11-06 | $403.05M 10-Q · filed 2025-11-06 | $527.18M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $138.32M 10-Q · filed 2025-08-06 | $266.45M 10-Q · filed 2025-08-06 | $390.58M derived: sum of 3 quarters · filed 2026-02-26 | $510.57M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $128.13M 10-Q · filed 2025-05-07 | $252.26M derived: sum of 2 quarters · filed 2026-02-26 | $372.25M derived: sum of 3 quarters · filed 2026-02-26 | $491.31M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $124.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $244.13M derived: sum of 2 quarters · filed 2026-02-26 | $363.18M derived: sum of 3 quarters · filed 2026-02-26 | $586.89M 10-K · filed 2026-02-26 |
| 2023-09-30 | $120.00M 10-Q · filed 2024-11-06 | $239.05M derived: sum of 2 quarters · filed 2024-11-06 | $462.76M 10-Q · filed 2024-11-06 | $558.75M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $119.05M 10-Q · filed 2024-07-31 | $342.76M 10-Q · filed 2024-07-31 | $438.76M derived: sum of 3 quarters · filed 2025-02-26 | $530.62M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $223.71M 10-Q · filed 2024-05-02 | $319.70M derived: sum of 2 quarters · filed 2025-02-26 | $411.56M derived: sum of 3 quarters · filed 2025-02-26 | $497.26M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $96.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $187.85M derived: sum of 2 quarters · filed 2025-02-26 | $273.55M derived: sum of 3 quarters · filed 2025-02-26 | $353.36M 10-K · filed 2025-02-26 |
| 2022-09-30 | $91.86M 10-Q · filed 2023-11-02 | $177.55M derived: sum of 2 quarters · filed 2023-11-02 | $257.36M 10-Q · filed 2023-11-02 | $329.02M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $85.69M 10-Q · filed 2023-08-03 | $165.50M 10-Q · filed 2023-08-03 | $237.16M derived: sum of 3 quarters · filed 2024-02-22 | $296.56M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $79.81M 10-Q · filed 2023-05-04 | $151.46M derived: sum of 2 quarters · filed 2024-02-22 | $210.87M derived: sum of 3 quarters · filed 2024-02-22 | $265.84M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $71.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $131.06M derived: sum of 2 quarters · filed 2024-02-22 | $186.03M derived: sum of 3 quarters · filed 2024-02-22 | $237.51M 10-K · filed 2024-02-22 |
| 2021-09-30 | $59.40M 10-Q · filed 2022-11-03 | $114.38M derived: sum of 2 quarters · filed 2022-11-03 | $165.86M 10-Q · filed 2022-11-03 | $221.36M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $54.98M 10-Q · filed 2022-08-04 | $106.45M 10-Q · filed 2022-08-04 | $161.96M derived: sum of 3 quarters · filed 2023-02-23 | $214.24M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $51.48M 10-Q · filed 2022-04-29 | $106.98M derived: sum of 2 quarters · filed 2023-02-23 | $159.26M derived: sum of 3 quarters · filed 2023-02-23 | $199.43M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $55.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $107.78M derived: sum of 2 quarters · filed 2023-02-23 | $147.95M derived: sum of 3 quarters · filed 2023-02-23 | $200.65M 10-K · filed 2023-02-23 |
| 2020-09-30 | $52.28M 10-Q · filed 2021-11-04 | $92.45M derived: sum of 2 quarters · filed 2021-11-04 | $145.15M 10-Q · filed 2021-11-04 | $189.93M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $40.16M 10-Q · filed 2021-07-28 | $92.86M 10-Q · filed 2021-07-28 | $137.65M derived: sum of 3 quarters · filed 2022-02-24 | $181.83M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $52.70M 10-Q · filed 2021-05-04 | $97.48M derived: sum of 2 quarters · filed 2022-02-24 | $141.67M derived: sum of 3 quarters · filed 2022-02-24 | $182.80M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $44.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $88.97M derived: sum of 2 quarters · filed 2022-02-24 | $130.10M derived: sum of 3 quarters · filed 2022-02-24 | $172.53M 10-K · filed 2022-02-24 |
| 2019-09-30 | $44.19M 10-Q · filed 2020-11-05 | $85.32M derived: sum of 2 quarters · filed 2020-11-05 | $127.75M 10-Q · filed 2020-11-05 | $170.17M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $41.13M 10-Q · filed 2020-07-31 | $83.56M 10-Q · filed 2020-07-31 | $125.98M derived: sum of 3 quarters · filed 2021-02-25 | $170.00M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $42.43M 10-Q · filed 2020-04-30 | $84.85M derived: sum of 2 quarters · filed 2021-02-25 | $128.87M derived: sum of 3 quarters · filed 2021-02-25 | $170.59M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $42.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $86.44M derived: sum of 2 quarters · filed 2021-02-25 | $128.17M derived: sum of 3 quarters · filed 2021-02-25 | $168.49M 10-K · filed 2021-02-25 |
| 2018-09-30 | $44.02M 10-Q · filed 2019-10-31 | $85.74M derived: sum of 2 quarters · filed 2019-10-31 | $126.06M 10-Q · filed 2019-10-31 | $169.41M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $41.73M 10-Q · filed 2019-07-25 | $82.05M 10-Q · filed 2019-07-25 | $125.39M derived: sum of 3 quarters · filed 2020-02-25 | $166.80M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $40.32M 10-Q · filed 2019-04-30 | $83.66M derived: sum of 2 quarters · filed 2020-02-25 | $125.08M derived: sum of 3 quarters · filed 2020-02-25 | $167.97M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $43.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $84.76M derived: sum of 2 quarters · filed 2020-02-25 | $127.65M derived: sum of 3 quarters · filed 2020-02-25 | $169.24M 10-K · filed 2020-02-25 |
| 2017-09-30 | $41.41M 10-Q · filed 2018-10-30 | $84.30M derived: sum of 2 quarters · filed 2018-10-30 | $125.90M 10-Q · filed 2018-10-30 | |
| 2017-06-30 | $42.89M 10-Q · filed 2018-08-01 | $84.49M 10-Q · filed 2018-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |